INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

LOOMIS SAYLES & CO L P's Holding History (CIK: 0000312348)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 428 Value ($000) $9 Avg Close — Range —
Q1 2021
Shares 1,662 Value ($000) $38 Avg Close — Range —
Q4 2020
Shares 6,748 Value ($000) $167 Avg Close — Range —
Q3 2020
Shares 7,529 Value ($000) $312 Avg Close — Range —
Q2 2020
Shares 7,529 Value ($000) $361 Avg Close — Range —
Q1 2020
Shares 51,617 Value ($000) $3,250 Avg Close — Range —
Q4 2019
Shares 65,465 Value ($000) $8,113 Avg Close — Range —
Q3 2019
Shares 86,969 Value ($000) $5,771 Avg Close — Range —
Q2 2019
Shares 90,645 Value ($000) $16,049 Avg Close — Range —
Q1 2019
Shares 89,889 Value ($000) $17,664 Avg Close — Range —
Q4 2018
Shares 173,055 Value ($000) $17,442 Avg Close — Range —
Q3 2018
Shares 181,264 Value ($000) $36,378 Avg Close — Range —
Q2 2018
Shares 430,234 Value ($000) $74,803 Avg Close — Range —
Q1 2018
Shares 442,975 Value ($000) $70,482 Avg Close — Range —
Q4 2017
Shares 465,862 Value ($000) $73,545 Avg Close — Range —
Q3 2017
Shares 261,383 Value ($000) $40,097 Avg Close — Range —
Q2 2017
Shares 166,005 Value ($000) $20,098 Avg Close — Range —
Q1 2017
Shares 170,563 Value ($000) $19,291 Avg Close — Range —
Q4 2016
Shares 26,438 Value ($000) $4,679 Avg Close — Range —